In non-small-cell lung cancer, miR-34a/b/c induced by wild-type P53 can bind to the 3′-UTR of PD-L1, promote the degradation of PD-L1 mRNA, and thereby inhibit the immune escape of non-small-cell lung cancer. The gene discussed is TP53; the disease is non-small cell lung carcinoma.